Case Studies

Tailored Intelligence Reports

Client:

Emerging specialist Biopharma company.

Client Challenge:

As part of their work developing novel therapies for women’s health and oncology, our client required applied regulatory intelligence to help guide their pipeline and clinical development decisions.

G&L Solution:

G&L's regulatory experts were utilized to provide detailed and thoroughly analyzed regulatory and competitor intelligence reports.

These included quarterly intelligence reports that were tailored to the specific needs of the client's Women's Health development portfolio across three areas of interest - Women’s Infertility, Uterine Fibroids, and Endometriosis.

G&L's work utilized multiple data sources to deliver robust intelligence reports covering Disease Background, Standard of Care, Competitor Landscape, Class Labeling, and Agency notifications.

As part of this work, G&L provided Impact Assessment and unique Insights relevant to the client’s portfolio/TA landscape.

Outcome:

In addition to our client-specific intelligence reports, G&L provided impact assessments and insights that helped the client make important clinical development decisions and pipeline prioritization.

Since this initial engagement, G&L now enjoys close ties with the client and is responsible for their entire oncology portfolio.

G&L's service and support are regarded as integral elements of the client’s regulatory strategy function and our tailored intelligence reports are firmly incorporated directly into the client's global regulatory and clinical development documents.